Nov/Dec2019

Latest stories

INDUSTRY TRENDS: BY THE NUMBERS

TOP 100 HEALTHCARE COMPANIES

Talent Trends: Keeping Yourself Safe When Navigating the Salary Ban

Trending Now

815 Views0 Comments
in Headlines

Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition

Wilmington, MA , February 17 2021 (Business Wire) — Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a definitive agreement to acquire Cognate BioServices, Inc., a premier, cell and gene therapy contract development and manufacturing organization (CDMO), for approximately $875 million in cash, subject to customary closing adjustments. The transaction is expected to close by the end of the first quarter of 2021, subject to regulatory requirements and customary closing conditions. More

by hsandm February 17, 2021, 7:13 pm

Read More
431 Views0 Comments
in Headlines

Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs

San Francisco, CA, February 17, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the completion of a $60 million financing. The proceeds will be used to advance Excision’s lead candidate, EBT-101, into a Phase 1/2 clinical trial in patients with chronic HIV infection. The financing will also support preclinical programs including EBT-103 targeting JC Virus for Progressive Multifocal Leukoencephalopathy (PML), EBT-104 for Herpes Simplex Virus, and EBT-107 for Hepatitis B. More

by hsandm February 17, 2021, 6:51 pm

Read More
1 Shares712 Views0 Comments
in Headlines

Henry Schein One Appoints New Chief Executive Officer

American Fork, UT, February 16, 2021 (BUSINESS WIRE) — Henry Schein One, a joint venture of Henry Schein, Inc., and Internet Brands, has announced that Mike Baird will assume the role of Chief Executive Officer, leading all aspects of Henry Schein One’s business. In his new role of CEO, Mr. Baird will lead the organization in driving growth, developing more seamlessly integrated products, and advancing digital innovations that help customers build stronger practices and deliver quality care. More

by hsandm February 16, 2021, 7:37 pm

Read More
902 Views0 Comments
in Headlines

Boehringer Ingelheim Animal Health USA Establishes Pawru, Inc.

Duluth, GA., February 16, 2021 (PRNewswire) — Boehringer Ingelheim Animal Health USA Inc. today announced the creation of Pawru, Inc. as a separate Company within the Boehringer Ingelheim Animal Health business. More

by hsandm February 16, 2021, 6:27 pm

Read More
803 Views0 Comments
in Headlines

AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock

New York NY, February 16 2021 (PRNewswire) — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 6,250,000 shares of common stock of the Company at a price to the public of $1.60 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 19, 2021, subject to satisfaction of customary closing conditions. More

by hsandm February 16, 2021, 6:17 pm

Read More
672 Views0 Comments
in Headlines

Jim Schuermann, 25 Year Industry Veteran, Appointed President & Chief Executive Officer of Saluda Medical

Artarmon, Australia, February 12, 2021 (PRNewswire) — Saluda Medical Pty Limited (“Saluda Medical”), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the treatment of chronic pain, today announced the appointment of Jim Schuermann as President & Chief Executive Officer. Mr. Schuermann joined Saluda Medical as President in June 2020. The company also announced that founder and CEO John Parker, PhD, will take on the new role of Chief Scientific Officer, while remaining on the company’s Board of Directors. More

by hsandm February 12, 2021, 3:48 pm

Read More

Nov/Dec2019

Latest stories

INDUSTRY TRENDS: BY THE NUMBERS

TOP 100 HEALTHCARE COMPANIES

Talent Trends: Keeping Yourself Safe When Navigating the Salary Ban

More stories

MOTIVIDEOS

The Cleveland Clinic Top 10 Innovations

KPMG REPORT ON MEDICAL DEVICES 2030

THE REGULATORY ATMOSPHERE: Execs From Smiths, Transenterix, Bausch and Tandem Offer Insights

Olympus Executive Director of Marketing, Peter Crowley, on Improving Patient Outcomes by Keeping the Focus on People

Senior Sales Director at Lilly and Company on the Lessons He Learned in War

November / December 2019

Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition

Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs

Henry Schein One Appoints New Chief Executive Officer

Boehringer Ingelheim Animal Health USA Establishes Pawru, Inc.

AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock

Jim Schuermann, 25 Year Industry Veteran, Appointed President & Chief Executive Officer of Saluda Medical

Latest stories

More stories

Log In

Sign In

Forgot password?

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections